Skip to content

Solana Company HSDT Deferred Offering Costs Reclassified To Equity Upon Public Offering

Deferred Offering Costs Reclassified To Equity Upon Public Offering at other companies

Regenxbio logo
RegenxbioRGNX
$124.75K-20.5%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
$5.05M
IRA
Iris Acquisition IRAB
$0
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$164.72K
ROC
Rank One Computing ROC
$226.8K
Verb Technology Company, Inc. logo
Verb Technology Company, Inc.TONX
$13.16M

Other financials

Income statement

See full
Revenue$3.6M+7,290%
Gross profit$3.4M+4,879%
Operating income-$99.6M-2,384%
Net income-$99.8M-2,500%
EPS (diluted)-$1.30+99.7%

Balance sheet

See full
Cash & equivalents$4.4M+296%
Total debt$12.0K-78.9%
Total equity$197.9M+15,361%
Total assets$200.7M+5,661%

Cash flow

See full
Operating cash flow-$4.8M-36.6%
CapEx$5.0K-73.7%
Free cash flow-$2.4M-16.7%

Valuation

See full
Market cap$96.34M+40,491%
P/S10.1×+9.2×

Profitability

See full
Gross margin94.2%+74.5pp
Operating margin-3,539.9%+225pp
Net margin-39,358.9%-41,297pp
FCF margin-2,124.2%+953pp

Returns & leverage

See full
Return on equity-344.3%-3,078pp
Debt / equity0.0×
Current ratio9.9×+8.2×

Where this comes from

Reported directly by Solana Company in its filing.

Tagged under the XBRL concept hsdt:DeferredOfferingCostsReclassifiedToEquityUponPublicOffering.

The official record: Solana Company ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solana Company 's deferred offering costs reclassified to equity upon public offering.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solana Company 's deferred offering costs reclassified to equity upon public offering?
Solana Company (HSDT) reported deferred offering costs reclassified to equity upon public offering of $8K in Q1 2025.
What does deferred offering costs reclassified to equity upon public offering mean?
Represents the non-cash transfer of previously capitalized offering costs into equity upon the successful completion of a public offering. This metric marks the final accounting recognition of costs associated with raising public capital.